Journal of Clinical Pathology and Laboratory Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Editorial - Journal of Clinical Pathology and Laboratory Medicine (2025) Volume 7, Issue 1

The role of cytokine storms in autoimmune disease progression: an immunopathological perspective.

Emily R. Carson*

Department of Clinical Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

*Corresponding Author:
Emily R. Carson
Department of Clinical Pathology
Johns Hopkins University School of Medicine
Baltimore, MD, USA
E-mail: ecarson@jhpathology.edu

Received: 06-Feb-2025, Manuscript No. AACPLM- 25-164066; Editor assigned: 07-Feb-2025, Pre QC No. AACPLM- 25-164066 (PQ); Reviewed: 10-Feb-2025, QC No. AACPLM-25-164066; Revised: 18-Feb-2025, Manuscript No. AACPLM- 25-164066 (R); Published: 28-Feb-2025, DOI: 10.35841/ aacplm-7.1.246

Citation: Carson ER. The role of cytokine storms in autoimmune disease progression: an immunopathological perspective. J Clin Path Lab Med.2025;(7)1:246

Introduction

Cytokine storms, also known as hypercytokinemia, represent an uncontrolled and excessive release of pro-inflammatory cytokines by the immune system. While this phenomenon is commonly associated with severe infectious diseases such as COVID-19 and influenza, it also plays a significant role in the pathogenesis and progression of autoimmune diseases. From an immunopathological standpoint, cytokine storms can drive tissue damage, amplify autoimmunity, and disrupt immune regulation, contributing to chronic disease activity and flare-ups in conditions like systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS).

In a healthy immune response, cytokines act as messengers that help coordinate the activation, proliferation, and differentiation of immune cells. However, in autoimmune diseases, a breakdown in self-tolerance triggers an aberrant immune response where the body attacks its own tissues. This is often accompanied by the overproduction of cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), IL-1β, and interferon-gamma (IFN-γ). These cytokines not only mediate inflammation but also recruit additional immune cells to the site, creating a self-amplifying cycle of immune activation and tissue injury [1-5].

One of the key immunopathological consequences of cytokine storms in autoimmune diseases is the destruction of target tissues. For instance, in RA, IL-6 and TNF-α promote the recruitment of neutrophils and macrophages into the synovial joints, leading to persistent inflammation, cartilage breakdown, and bone erosion. In SLE, elevated levels of type I interferons and IL-10 are associated with increased autoantibody production and immune complex deposition, resulting in multi-organ damage, particularly in the kidneys, skin, and central nervous system.

Moreover, cytokine storms can disturb the delicate balance between pro-inflammatory and regulatory immune responses. Regulatory T cells (Tregs), which normally suppress excessive immune activity, are often dysfunctional or reduced in autoimmune settings. Simultaneously, the expansion of Th17 cells, known for secreting IL-17, further fuels inflammation. This imbalance perpetuates the autoimmune cycle, making disease remission difficult to achieve without targeted intervention [6-10].

From a clinical perspective, understanding the role of cytokine storms in autoimmune disease progression has paved the way for targeted therapies. Biologic drugs such as TNF inhibitors, IL-6 receptor blockers (e.g., tocilizumab), and Janus kinase (JAK) inhibitors have shown efficacy in mitigating the effects of cytokine-driven inflammation. These treatments aim to interrupt the signaling pathways involved in cytokine production and immune cell activation, thereby reducing tissue damage and improving patient outcomes.

Conclusion

In conclusion, cytokine storms play a critical immunopathological role in the progression of autoimmune diseases. Their contribution to inflammation, tissue destruction, and immune dysregulation highlights the importance of cytokine-targeted therapies in disease management. Continued research into cytokine signaling and immune modulation holds promise for more precise and effective interventions in autoimmune disorders.

References

  1. Andersen L, Bratland A, Hodneland K, et al. Tissue tropism of salmonid alphaviruses (subtypes SAV1 and SAV3) in experimentally challenged Atlantic salmon (Salmo salar L.). Arch Virol. 2007;152(10):1871-83.

    2. Indexed at, Google Scholar, Cross Ref

  2. Andersen L, Hodneland K, Nylund A. No influence of oxygen levels on pathogenesis and virus shedding in Salmonid alphavirus (SAV)-challenged Atlantic salmon (Salmo salar L.). J Virol. 2010;7(1):1-4.

    3. Indexed at, Google Scholar, Cross Ref

  3. Forrester NL, Palacios G, Tesh RB, et al. Genome-scale phylogeny of the alphavirus genus suggests a marine origin. J Virol. 2012;86(5):2729-38.

    4. Indexed at, Google Scholar, Cross Ref

  4. Feng C, Wang H, Lu N, et al. Log transformation: application and interpretation in biomedical research. Stat Med. 2013;32(2):230-9.

    5. Indexed at, Google Scholar, Cross Ref

  5. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. American journal of epidemiology. 2007;165(6):710-8.

    6. Indexed at, Google Scholar, Cross Ref

  6. Advani R, Flinn I, Popplewell L, et al. CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin’s lymphoma. N Engl J Med. 2018;379(18):1711-21.

    7. Indexed at, Google Scholar, Cross Ref

  7. Baize S, Leroy EM, Georges AJ, et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol. 2002;128(1):163-8.

    8. Indexed at, Google Scholar, Cross Ref

  8. Baize S, Leroy EM, Georges-Courbot MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med. 1999;5(4):423-6.

    9. Indexed at, Google Scholar, Cross Ref

  9. Gevers W. Protein metabolism of the heart. J Mol Cell Cardiol. 1984;16(1):3-2.

    10. Indexed at, Google Scholar, Cross Ref

  10. Nath S. The thermodynamic efficiency of ATP synthesis in oxidative phosphorylation. Biophysical chemistry. 2016;219:69-74.

    11. Indexed at, Google Scholar, Cross Ref

Get the App